AstraZeneca Stocks Drops as $2 Billion Buys an Oncology Option

The Summit investment secures trial access without transferring ownership of either company's cancer medicine.

Oct 2, 2026 - 06:00
 0  1
AstraZeneca Stocks Drops as $2 Billion Buys an Oncology Option
The Summit investment secures trial access without transferring ownership of either company's cancer medicine.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow